Research Article
Using Nodal Ratios to Predict Risk of Regional Recurrences in Patients Treated with Breast Conservation Therapy with 4 or More Positive Lymph Nodes
Table 1
Patient characteristics as a function of nodal ratio.
| Clinical parameter | LNR (%) | INR (%) | HNR (%) | Total (100%) |
| Patient age | | | | | ā<50 years | 3 (15) | 11 (52) | 7 (33) | 21 | āā„50 years | 13 (38) | 11 (31) | 11 (31) | 35 |
| Tumor size | | | | | āT1 | 6 (21) | 11 (39) | 11 (39) | 28 | āT2 | 10 (36) | 11 (39) | 7 (25) | 28 |
| Pathologic subtype | | | | | āInvasive ductal | 16 (31) | 20 (38) | 16 (31) | 52 | āInvasive lobular | 0 (0) | 1 (50) | 1 (50) | 2 | āOther | 0 (0) | 1 (50) | 1(50) | 2 |
| Estrogen status | | | | | āPositive | 9 (35) | 11 (42) | 6 (23) | 26 | āNegative | 4 (19) | 8 (38) | 9 (43) | 21 |
| Progesterone status | | | | | āPositive | 10 (39) | 11 (42) | 5 (19) | 26 | āNegative | 3 (17) | 6 (33) | 9 (50) | 18 |
| Chemotherapy | | | | | āYes | 10 (63) | 20 (91) | 16 (89) | 46 | āNo | 6 (37) | 2 (9) | 2 (11) | 10 |
|
|
Abbreviations/definitions: LNR = low nodal ratio <40%; INR = Intermediate Nodal Ratio, 40%ā70%; HNR = High Nodal Ratio >70%.
|